Giulia Pasello

TL;DR: In advanced non-squamous non-oncogene addicted non-small cell lung cancer (NSCLC), the use of bevacizumab—a monoclonal antibody targeting vascular endothelial growth factor (VEGF)—in addition to platinum-doublet is approved for first-line treatment.

TL;DR: In this article, the authors determined predictors of unresectability of mesothelioma, testing the impression that the contraction of the ipsilateral hemithorax is often associated with exploratory thoracotomy.

TL;DR: Predictors and prognostic-economic impact of nivolumab in etd patients are defined and risk of death was significantly higher in cohort 2 or cohort 1 with etd compared with cohort 1 without etd, and the BI gap was 857 188 euros ($969 050).

TL;DR: In this article, the authors report a 10-year Padova experience in the surgical pathology of the thymus, focusing on the pathological description of nonneoplastic lesions and rare epithelial and mesenchymal tumors recorded in their database, which comprises over 600 thymectomies.